Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-17-006257
Filing Date
2017-06-26
Accepted
2017-06-26 15:46:59
Documents
1
Period of Report
2017-08-01
Effectiveness Date
2017-06-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1701903-def14a.htm DEF 14A 285971
  Complete submission text file 0001571049-17-006257.txt   287058
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-13341 | Film No.: 17929855
SIC: 2836 Biological Products, (No Diagnostic Substances)